Jinhua Mingzhu Pharmaceutical Co., Ltd.

Jinhua Pearl Pharmaceutical Corporation is a company of limited liability and GMP certification enterprise (certificate no. Zhejiang F0168) set up in Feb. 2003, approved by Zhejiang Drug Administration. The company now owns fixed capital RMB 28 million, and occupies floor area 30, 000 square meters, building area 8, 000 square meters. It is provided with solid preparation workshop, Chinese traditional medicine extraction workshop and composite pharmaceutical product workshop. Also it has the self-support import and export rights of commodity and technique.

The product scope of company includes Chinese medical preparation, pharmaceutical product and bismuth salt.

The major pharmaceutical product is bismuth salt, which includes basic bismuth nitrate, bismuth subcarbonate, bismuth aluminate, bismuth subsalicylate, bismuth subgallate, and lansoprazole, etc. These products are now exported to Europe, America, Japan, Korea and Southeast Asia, etc.

Baokang Refine Chemical Industry Plant subordinated to our company is a manufacturer with more than one decade processing experience of bismuth salt products. The major products are bismuth oxide, bismuth nitrate and bismuth oxychloride.

Our company sticks to the development concept of continuous innovation, scientific management and human-oriented. "Quality first, customer satisfied" is our business principle. Honest and credible, we endeavor to establish the cooperation relationship on a reciprocal basis with dealers and agents, and expand the medicine market both in China and abroad, with the service idea of "for customer's success" in mind.

Our company sincerely invites the agents that have certain market sales experience and development force to deputize stilbene pallas capsule and other new drugs in Chinese and overseas markets. Meanwhile, we welcome talents to join us for the bright future for both.